HMMR promotes invasion and metastasis of hepatocellular carcinoma via activating MEK/ERK signaling pathway

HMMR promotes invasion and metastasis of hepatocellular carcinoma via activating MEK/ERK signaling pathway

Objective To investigate the effect of hyaluronan-mediated motility receptor (HMMR) on the invasion and metastasis of hepatocellular carcinoma (HCC) cells. Methods The expression levels of HMMR in HCC cell lines and tissues were detected by qRT-PCR, Western blotting and immunohistochemical assay. T...

Full description

Bibliographic Details
Main Authors:	LI Xun, YAN Jiao, CAI Shunli, CHEN Huajian
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Army Medical University 2022-09-01
Series:	陆军军医大学学报
Subjects:	hepatocellular carcinoma hyaluronan-mediated motility receptor epithelial-mesenchymal transition metastasis mek/erk signaling pathway
Online Access:	http://aammt.tmmu.edu.cn/Upload/rhtml/202203004.htm

Similar Items

RNF173 suppresses RAF/MEK/ERK signaling to regulate invasion and metastasis via GRB2 ubiquitination in Hepatocellular Carcinoma
by: Jie Zhou, et al.
Published: (2023-08-01)

The Effects of a Novel MEK Inhibitor PD184161 on MEK-ERK Signaling and Growth in Human Liver Cancer
by: Patrick J. Klein, et al.
Published: (2006-01-01)

MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence
by: Mingyu Liu, et al.
Published: (2018-01-01)

A Positive Feedback Loop of lncRNA HOXD-AS2 and SMYD3 Facilitates Hepatocellular Carcinoma Progression via the MEK/ERK Pathway
by: Sun J, et al.
Published: (2023-07-01)

PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer
by: Hanpu Zhang, et al.
Published: (2022-12-01)

The MEK/ERK Module Is Reprogrammed in Remodeling Adult Cardiomyocytes
by: Thomas Kubin, et al.
Published: (2020-09-01)

Rigosertib inhibits MEK1–ERK pathway and alleviates lipopolysaccharide‐induced sepsis
by: Yin Wang, et al.
Published: (2021-09-01)

Caspase 3‐specific cleavage of MEK1 suppresses ERK signaling and sensitizes cells to stress‐induced apoptosis
by: Hisashi Moriizumi, et al.
Published: (2023-04-01)

LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK/ERK signaling pathway
by: Ziye Chen, et al.
Published: (2021-09-01)

SERPINA11 Inhibits Metastasis in Hepatocellular Carcinoma by Suppressing MEK/ERK Signaling Pathway
by: Song Y, et al.
Published: (2021-07-01)

Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition
by: Antonella Catalano, et al.
Published: (2021-04-01)

Bruceine A: Suppressing metastasis via MEK/ERK pathway and invoking mitochondrial apoptosis in triple-negative breast cancer
by: Xiao Li, et al.
Published: (2023-12-01)

Zyxin Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma via Rap1-Mediated Inhibition of the MEK/ERK Signaling Pathway
by: Zhun Wei, et al.
Published: (2023-08-01)

KIF15 promotes bladder cancer proliferation via the MEK–ERK signaling pathway
by: Zhao H, et al.
Published: (2019-02-01)

CircRNA CDR1as/miR-1287/Raf1 Axis Modulates Hepatocellular Carcinoma Progression Through MEK/ERK Pathway
by: Zhang B, et al.
Published: (2020-09-01)

Cobimetinib and trametinib inhibit platelet MEK but do not cause platelet dysfunction
by: Amanda J. Unsworth, et al.
Published: (2019-08-01)

Generation and characterization of MEK and ERK inhibitors- resistant non-small-cells-lung-cancer (NSCLC) cells
by: Alice Iezzi, et al.
Published: (2018-10-01)

Combination therapies to inhibit the RAF/MEK/ERK pathway in melanoma: we are not done yet.
by: Grant A. McArthur
Published: (2015-07-01)

Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK/ERK signal pathway
by: Mei Ren, et al.
Published: (2019-12-01)

Tetrandrine sensitizes nasopharyngeal carcinoma cells to irradiation by inducing autophagy and inhibiting MEK/ERK pathway
by: Jun Wang, et al.
Published: (2020-10-01)

Ras/Raf/MEK/ERK pathway activation in childhood acute lymphoblastic leukemia and its therapeutic targeting
by: Thomas eKnight, et al.
Published: (2014-06-01)

Xanthotoxin, a novel inducer of platelet formation, promotes thrombocytopoiesis via IL-1R1 and MEK/ERK signaling
by: Jia Lai, et al.
Published: (2023-07-01)

Influence of RKIP Protein Complexes Concentrations on the Quasi-Stationary Behaviour of the MEK/ERK Signal Transduction Pathway
by: Petrov V., et al.
Published: (2007-12-01)

Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway
by: Shuang Wang, et al.
Published: (2020-08-01)

Deregulation of Hepatic Mek1/2–Erk1/2 Signaling Module in Iron Overload Conditions
by: Naveen Kumar Tangudu, et al.
Published: (2019-05-01)

Plectin Downregulation Inhibits Migration and Suppresses Epithelial Mesenchymal Transformation of Hepatocellular Carcinoma Cells via ERK1/2 Signaling
by: Rushuang Xu, et al.
Published: (2022-12-01)

Rapamycin inhibits cardiac hypertrophy by promoting autophagy via the MEK/ERK/Beclin-1 pathway
by: Changqian eWang, et al.
Published: (2016-03-01)

Propylene Glycol Alginate Sodium Sulfate Alleviates Cerulein‐Induced Acute Pancreatitis by Modulating the MEK/ERK Pathway in Mice
by: Hui Zhang, et al.
Published: (2017-02-01)

Cysteine protease inhibitor 1 promotes metastasis by mediating an oxidative phosphorylation/MEK/ERK axis in esophageal squamous carcinoma cancer
by: Liangming Zhang, et al.
Published: (2024-02-01)

Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway
by: Zhang Xiangchao, et al.
Published: (2023-06-01)

Butein inhibits corticosterone-induced apoptosis of Neuro2A cells by maintaining MEK-ERK signaling
by: Masanori Ohmoto, et al.
Published: (2023-06-01)

Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
by: Irem Ozkan-Dagliyan, et al.
Published: (2020-06-01)

High Expression of Heterogeneous Nuclear Ribonucleoprotein A1 Facilitates Hepatocellular Carcinoma Growth
by: Cao Z, et al.
Published: (2023-04-01)

Inhibition of the MEK/ERK pathway suppresses immune overactivation and mitigates TDP-43 toxicity in a Drosophila model of ALS
by: Wenkai Yue, et al.
Published: (2023-06-01)

Managing Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors Through Co-Targeting MEK/ERK Signaling
by: Yu D, et al.
Published: (2021-02-01)

FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR
by: Lei Li, et al.
Published: (2019-10-01)

Oxymatrine Inhibits Proliferation and Migration of Vulvar Squamous Cell Carcinoma Cells via Attenuation of the RAS/RAF/MEK/ERK Pathway
by: Wang Y, et al.
Published: (2020-03-01)

Puerarin inhibits hepatocellular carcinoma invasion and metastasis through miR-21-mediated PTEN/AKT signaling to suppress the epithelial-mesenchymal transition
by: Yuan Zhou, et al.

Biphasic regulation of osteoblast development via the ERK MAPK–mTOR pathway
by: Jung-Min Kim, et al.
Published: (2022-08-01)

TMEM106A transcriptionally regulated by promoter methylation is involved in invasion and metastasis of hepatocellular carcinoma
by: Shi Shiming, et al.
Published: (2022-06-01)